incretin glp 1 Evolution of (GLP-1 and GIP) and its receptors. Abbreviations: GLP-1 is released from the
Description
This is perhaps the most important unknown in the entire field
Yan W, Pang M, Yu Y, et al
Results from drug trials support claims that GLP-1s are different than other weight loss medications, not only in terms of mechanism of action but also health benefits
Patients with a history of pancreatitis, severe gastrointestinal disease, gallbladder problems, certain endocrine cancers, or complex medication regimens should be evaluated carefully before considering incretin-based therapies
